DeepMed Research

Fudan University

🇨🇳China

Country: 🇨🇳China

Ownership: Private

Established: 1905-01-01

Employees: 1K

Market Cap: -

Website: http://www.fudan.edu.cn

Clinical Trials

Sintilimab Plus Chemotherapy Followed by dCRT in Locally Advanced ESCC

Phase 2

Completed

Conditions: Esophageal Squamous Cell Carcinoma

Interventions: Drug: Sintilimab plus Chemotherapy

First Posted Date: 2019-06-13

Last Posted Date: 2024-11-07

Lead Sponsor: Fudan University

Target Recruit Count: 75

Registration Number: NCT03985046

Locations: 🇨🇳
Fudan Universtiy Shanghai Cancer Center, Shanghai, Shanghai, China

Efficacy and Safety of Anlotinib in Adjuvant Therapy for High-grade Soft Tissue Sarcoma

Phase 2

Completed

Conditions: Soft Tissue Sarcoma Adult
High Grade Sarcoma

Interventions: Drug: Anlotinib Hydrochloride
Drug: Placebo Oral Tablet

First Posted Date: 2019-05-15

Last Posted Date: 2025-05-14

Lead Sponsor: Fudan University

Target Recruit Count: 88

Registration Number: NCT03951571

Locations: 🇨🇳
Cancer Hospital of Sun Yat-sen, Guangzhou, Guangdong, China
🇨🇳
Yunnan Cancer Hospital, Kunming, Yunnan, China
🇨🇳
Zhengjiang Cancer Hospital, Hangzhou, Zhejiang, China

and more 2 locations

Cardiac Safety and Efficacy for Early-stage Breast Cancer Patients Treated With Pegylated Liposomal Doxorubicin（PLD)

Phase 3

Conditions: Early Breast Cancer

Interventions: Drug: PLD
Drug: CTX
Drug: Docetaxel
Drug: Paclitaxel
Drug: Doxorubicin

First Posted Date: 2019-05-14

Last Posted Date: 2019-05-14

Lead Sponsor: Fudan University

Target Recruit Count: 272

Registration Number: NCT03949634

Locations: 🇨🇳
Fudan University affiliated cancer hospital, Shanghai, China

S-1 for 9 Months Versus 1 Year for Stage II Gastric Cancer (SMAC）

Phase 3

Recruiting

Conditions: Gastric Cancer

Interventions: Drug: S-1 for 9 months
Drug: S-1 for 1 year

First Posted Date: 2019-05-08

Last Posted Date: 2019-05-31

Lead Sponsor: Fudan University

Target Recruit Count: 1006

Registration Number: NCT03941561

Locations: 🇨🇳
Dazhi Xu, Shanghai, China
🇨🇳
First Affiliated Hospital of Wannan Medical College, Wuhu, China
🇨🇳
Anqing Municipal Hospital, Anqing, China

and more 3 locations

Nab-paclitaxel and Gemcitabine in Metastatic Pancreatic Cancer

Phase 2

Conditions: Metastatic Pancreatic Cancer

Interventions: Drug: Paclitaxel for Injection（Albumin Bound）
Drug: Gemcitabine

First Posted Date: 2019-04-26

Last Posted Date: 2019-04-26

Lead Sponsor: Fudan University

Target Recruit Count: 120

Registration Number: NCT03929094

Locations: 🇨🇳
FUDAN University, Shanghai, Shanghai, China

Study Comparing 4 Cycles With 6 Cycles of TC (Docetaxel+Cyclophosphamide) Adjuvant Chemotherapy for 1-3 Lymph Node Positive ER+/HER2- Early Breast Cancer

Phase 3

Recruiting

Conditions: Breast Cancer

Interventions: Drug: Docetaxel
Drug: Cyclophosphamide

First Posted Date: 2019-04-24

Last Posted Date: 2023-11-14

Lead Sponsor: Fudan University

Target Recruit Count: 2172

Registration Number: NCT03926091

Locations: 🇨🇳
The First Hospital of China Medical University, Shenyang, Liaoning, China
🇨🇳
The First Bethune Hospital of Jilin University (The First Hospital of Jilin University), Changchun, Jilin, China
🇨🇳
The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China

and more 11 locations

Local Therapy for Oligorecurrent and Oligometastatic Esophageal Squamous Cell Carcinoma

Phase 2

Completed

Conditions: Oligorecurrent and Oligometastatic Esophageal Squamous Cell Carcinoma

Interventions: Other: Radiation, Surgery or Radiofrequency ablation
Drug: Systemic therapy

First Posted Date: 2019-04-05

Last Posted Date: 2024-10-23

Lead Sponsor: Fudan University

Target Recruit Count: 104

Registration Number: NCT03904927

Locations: 🇨🇳
Fudan Universtiy Shanghai Cancer Center, Shanghai, Shanghai, China

Real World Study of Lapatinib Among Metastatic Breast Cancer Patients

Completed

Conditions: Breast Cancer

First Posted Date: 2019-03-28

Last Posted Date: 2024-02-26

Lead Sponsor: Fudan University

Target Recruit Count: 242

Registration Number: NCT03894410

Locations: 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China

The Maintenance Treatment of Apatinib/Capecitabine Versus Observation in Advanced Gastric Cancer

Phase 3

Conditions: Capecitabine
Molecular Mechanisms of Pharmacological Action
Stomach Neoplasms
Digestive System Neoplasms
Apatinib
Stomach Diseases
Gastrointestinal Neoplasms
Neoplasms

Interventions: Drug: Apatinib
Drug: Capecitabine

First Posted Date: 2019-03-26

Last Posted Date: 2019-03-26

Lead Sponsor: Fudan University

Target Recruit Count: 242

Registration Number: NCT03889626

The Effects of Preoperatively Chewing Gum on Sore Throat After General Anaesthesia With a Laryngeal Mask

Phase 1

Conditions: Postoperative Sore Throat

Interventions: Other: swallow twice
Drug: chewed mint gum

First Posted Date: 2019-03-22

Last Posted Date: 2019-06-10

Lead Sponsor: Fudan University

Target Recruit Count: 70

Registration Number: NCT03885752

Locations: 🇨🇳
Ethics Committee of The Obstetrics and Gynecology Hospital, Fudan University,, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy